Neurophet Supplies Brain Imaging Software to Raffles Medical in Singapore

July 03, 2026
Neurophet has signed an agreement to supply its brain imaging analysis software, Neurophet AQUA, to Raffles Medical in Singapore. The software enables fast quantitative analysis of MRI scans for assessing brain atrophy and white matter degeneration in neurodegenerative diseases.

Neurophet announced in a press release that it has signed a supply agreement with Raffles Medical in Singapore for its neurodegenerative brain imaging analysis software, Neurophet AQUA.

Neurophet AQUA performs quantitative analysis of brain MRI scans, allowing clinicians to assess brain atrophy and white matter degeneration. The software measures structural changes associated with neurodegenerative diseases such as Alzheimer's disease and vascular dementia. It generates analysis reports tailored to each patient.

Raffles Medical is part of Raffles Medical Group, which operates more than 100 clinics across Singapore and Asia. The clinics are connected to Raffles Hospital and Raffles Specialist Centres, providing access to diagnostic and specialist services.

Neurophet has previously collaborated with local institutions including the Dementia Research Centre at Nanyang Technological University, the National University of Singapore, and Singapore General Hospital. The company develops AI based diagnostic and treatment support tools for brain disorders, with products including Neurophet SCALE PET, Neurophet tES/TMS LAB, and Neurophet AQUA AD.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

07/03
SK bioscience Leads Gates Foundation-Funded AI Vaccine Project
07/02
Experity Acquires Exdion Healthcare to Expand AI Revenue Cycle Automation
07/02
Alleva Launches Alleva Intelligence for Behavioral Health Operations
07/02
Insilico Medicine and Takeda Form $600 Million AI Drug Discovery Partnership
07/01
ALR Technologies to Acquire CGM Medical Technology for $45 Million and 200 Million Shares

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like